Location History:
- Hanover, DE (1979 - 1985)
- Peine, DE (1976 - 1986)
Company Filing History:
Years Active: 1976-1986
Title: Renke Budden: Innovator in Pharmaceutical Chemistry
Introduction
Renke Budden, based in Peine, Germany, is a notable inventor with a portfolio of 11 patents primarily in the field of pharmaceutical chemistry. His contributions to drug development, particularly in the realm of benzodiazepine derivatives, have significant implications for therapeutic applications.
Latest Patents
Among his recent patents, Renke Budden has detailed a novel process for making benzodiazepine derivatives. This innovative approach involves converting benzodiazocines to benzodiazepines through specific thermal treatments or the application of Lewis acids. His work also includes the development of new quaternary derivatives of ajmaline and isoajmaline. These derivatives have been found to exhibit antiarrhythmic and adrenolytic properties, contributing to advancements in pharmaceutical formulations.
Career Highlights
Renke Budden has amassed considerable experience throughout his career, having worked with notable companies such as Kali-Chemie Aktiengesellschaft and Kali-Chemie Pharma GmbH. His tenure at these companies has allowed him to refine his expertise and foster innovations within the pharmaceutical industry.
Collaborations
Throughout his professional journey, Renke Budden has collaborated with other accomplished professionals, including Wolfgang Milkowski and Horst Zeugner. These collaborations have enabled the exchange of ideas and fostered advancements in the development of pharmaceutical compounds.
Conclusion
Renke Budden's work represents a significant contribution to the field of pharmaceutical chemistry. His innovative processes and collaborative efforts highlight the importance of research and development in creating effective therapeutic agents. Through his patents and career achievements, Budden continues to influence the landscape of drug development and innovation.